MENU
ATNM
AS OF
Dec 3, 04:59 PM (EDT)
Price
$1.45
Change
+$0.07 (+5.07%)
Capitalization
42.74M
99 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
ATNM
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION

Actinium Pharmaceuticals (ATNM) Earnings Date & Reports

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

ATNM is expected to report earnings to rise 12.50% to -18 cents per share on March 13

Actinium Pharmaceuticals ATNM Stock Earnings Reports
Q4'25
Est.
$-0.18
Q3'25
Beat
by $0.16
Q2'25
Beat
by $0.13
Q1'25
Missed
by $0.13
Q4'24
Beat
by $0.16
The last earnings report on November 24 showed earnings per share of -15 cents, beating the estimate of -31 cents. With 103.17K shares outstanding, the current market capitalization sits at 42.74M.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
ATNM
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ATNM showed earnings on November 24, 2025. You can read more about the earnings report here.
View AI-Driven Trading for ATNM
A.I. Advisor
published General Information

General Information

a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
100 Park Avenue
Phone
+1 646 677-3870
Employees
49
Web
https://www.actiniumpharma.com